Evidence map›Paper›PMID 39972127›Full record

ArticleNature2025

Mechanism for local attenuation of DNA replication at double-strand breaks.

Robin Sebastian, Eric G Sun, Michael Fedkenheuer, Haiqing Fu, SeolKyoung Jung, Bhushan L Thakur, Christophe E Redon, Gianluca Pegoraro, Andy D Tran, Jacob M Gross and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. In vivo systematic detection of the outcomes of CRISPR-Cas9-mediated DNA repair in skeletal muscle stem cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Programmable electric tweezers.Science advances · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Robin SebastianDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-6495-2615
Eric G SunDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-9109-1969
Michael FedkenheuerMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2715-2904
Haiqing FuDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-4764-1422
SeolKyoung JungBiodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0009-0004-7679-5919
Bhushan L ThakurDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8426-3478
Christophe E RedonDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Gianluca PegoraroHigh Throughput Imaging Facility (HiTIF), National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-2843-9464
Andy D TranCCR Microscopy Core Facility, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.ORCID 0000-0002-2388-7121
Jacob M GrossDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sara MosavarpourDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nana Afua KusiDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Anagh RayDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2380-6467
Anjali DhallDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Lorinc S PongorDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-5917-4628
Rafael CasellasMolecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-9282-2287
Mirit I AladjemDevelopmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. aladjemm@nih.gov.ORCID 0000-0002-1875-3110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) disrupt the continuity of the genome, with consequences for malignant transformation. Massive DNA damage can elicit a cellular checkpoint response that prevents cell proliferation

Indexed as

DNA Breaks, Double-StrandedDNA ReplicationCell Cycle ProteinsCell Line, TumorChromatinDNA RepairGenomic InstabilityHumansIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesReplication OriginCell Cycle ProteinsChromatinIntracellular Signaling Peptides and ProteinsNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesWEE1 protein, human

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.